Castlight Health Inc. (NYSE:CSLT) CEO Giovanni M. Colella sold 3,526 shares of the stock in a transaction on Wednesday, November 16th. The stock was sold at an average price of $4.99, for a total value of $17,594.74. Following the completion of the sale, the chief executive officer now owns 31,956 shares in the company, valued at approximately $159,460.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Castlight Health Inc. (NYSE:CSLT) opened at 4.90 on Friday. The stock has a 50 day moving average price of $4.26 and a 200 day moving average price of $4.13. Castlight Health Inc. has a 12-month low of $2.54 and a 12-month high of $5.15. The stock’s market cap is $508.15 million.

Castlight Health (NYSE:CSLT) last issued its earnings results on Wednesday, November 2nd. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.04. The company earned $25.50 million during the quarter, compared to the consensus estimate of $24.81 million. Castlight Health had a negative net margin of 73.57% and a negative return on equity of 58.57%. Castlight Health’s quarterly revenue was up 30.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.17) EPS. On average, analysts forecast that Castlight Health Inc. will post ($0.34) earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Castlight Health (NYSE:CSLT)

A number of equities research analysts recently issued reports on the company. FBR & Co reiterated a “hold” rating and issued a $4.00 price objective on shares of Castlight Health in a research report on Wednesday, August 10th. Morgan Stanley restated a “hold” rating and set a $4.00 price target on shares of Castlight Health in a research report on Thursday, August 25th. Zacks Investment Research upgraded Castlight Health from a “hold” rating to a “buy” rating and set a $5.00 price target on the stock in a research report on Friday, August 12th. Finally, Canaccord Genuity restated a “hold” rating and set a $5.00 price target on shares of Castlight Health in a research report on Sunday, September 11th. Six investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $4.58.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Bank of Montreal Can increased its position in shares of Castlight Health by 4,752.0% in the third quarter. Bank of Montreal Can now owns 24,260 shares of the company’s stock valued at $101,000 after buying an additional 23,760 shares in the last quarter. The Manufacturers Life Insurance Company purchased a new position in shares of Castlight Health during the third quarter valued at $132,000. Rhumbline Advisers increased its position in shares of Castlight Health by 2.1% in the third quarter. Rhumbline Advisers now owns 32,087 shares of the company’s stock valued at $133,000 after buying an additional 650 shares in the last quarter. Metropolitan Life Insurance Co. NY purchased a new position in shares of Castlight Health during the second quarter valued at $136,000. Finally, Stifel Financial Corp increased its position in shares of Castlight Health by 40.9% in the second quarter. Stifel Financial Corp now owns 38,330 shares of the company’s stock valued at $152,000 after buying an additional 11,130 shares in the last quarter. 51.71% of the stock is owned by institutional investors.

About Castlight Health

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its products deliver employee engagement and enable employers to integrate benefit programs into a single platform available to employees and their families.

5 Day Chart for NYSE:CSLT

Receive News & Stock Ratings for Castlight Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health Inc. and related stocks with our FREE daily email newsletter.